PE859, a Novel Tau Aggregation Inhibitor, Reduces Aggregated Tau and Prevents Onset and Progression of Neural Dysfunction In Vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PE859, a Novel Tau Aggregation Inhibitor, Reduces Aggregated Tau and Prevents Onset and Progression of Neural Dysfunction In Vivo
Authors
Keywords
Spinal cord, Methylene blue, Alzheimers disease, Central nervous system, Microtubules, Mouse models, Oral administration, Tau protein
Journal
PLoS One
Volume 10, Issue 2, Pages e0117511
Publisher
Public Library of Science (PLoS)
Online
2015-02-07
DOI
10.1371/journal.pone.0117511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Specific Targeting of Tau Oligomers in Htau Mice Prevents Cognitive Impairment and Tau Toxicity Following Injection with Brain-Derived Tau Oligomeric Seeds
- (2016) Diana L. Castillo-Carranza et al. JOURNAL OF ALZHEIMERS DISEASE
- Mechanistic Basis of Phenothiazine-Driven Inhibition of Tau Aggregation
- (2013) Elias Akoury et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Accelerated neurodegeneration through chaperone-mediated oligomerization of tau
- (2013) Laura J. Blair et al. JOURNAL OF CLINICAL INVESTIGATION
- Tau Oligomers as Potential Targets for Alzheimer’s Diagnosis and Novel Drugs
- (2013) Leonardo Guzmán-Martinez et al. Frontiers in Neurology
- Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
- (2012) Erin E. Congdon et al. Autophagy
- Tau oligomers and tau toxicity in neurodegenerative disease
- (2012) Sarah M. Ward et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
- (2012) Masato Hosokawa et al. PLoS One
- Progression of Tau Pathology in Cholinergic Basal Forebrain Neurons in Mild Cognitive Impairment and Alzheimer's Disease
- (2011) Laurel Vana et al. AMERICAN JOURNAL OF PATHOLOGY
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)
- (2011) Dennis W. Dickson et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Unknown
- (2011) Adriana Ferreira et al. MOLECULAR MEDICINE
- Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
- (2011) Cristian A Lasagna-Reeves et al. Molecular Neurodegeneration
- Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
- (2010) John C O'Leary et al. Molecular Neurodegeneration
- Three-/four-repeat-dependent aggregation profile of tau microtubule-binding domain clarified by dynamic light scattering analysis
- (2009) Etsuko Sugino et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy
- (2009) C. Wischik et al. Journal of Nutrition Health & Aging
- Linkage-dependent contribution of repeat peptides to self-aggregation of three- or four-repeat microtubule-binding domains in tau protein
- (2008) Kayoko Okuyama et al. FEBS Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More